Growth hormone cotreatment for low-prognosis patients according to the POSEIDON criteria

X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - frontiersin.org
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …

The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response

S Dogan, OSY Cicek, M Demir, L Yalcinkaya… - Journal of gynecology …, 2021 - Elsevier
Low response of patients with diminished ovarian reserve to exogenous gonadotropins in
controlled ovarian stimulation (COS) protocols is one of the important problems of …

The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment …

M Cai, L Gao, XY Liang, C Fang, Y Wu… - Frontiers in …, 2019 - frontiersin.org
The aim of this retrospective analysis is to explore whether growth hormone (GH)
pretreatment is beneficial for patients with poor ovarian reserve undertaking in vitro …

Six‐week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: A self‐controlled …

MH Cai, XY Liang, YQ Wu, R Huang… - Journal of Obstetrics …, 2019 - Wiley Online Library
Aim The purpose was to explore whether the 6 weeks of growth hormone (GH) pretreatment
could increase the live birth rate of poor ovarian responders (POR). Methods This self …

[HTML][HTML] Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis

X Yu, J Ruan, LP He, W Hu, Q Xu, J Tang… - … journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Growth hormone (GH) is involved in the regulation of male and female infertility. Several
clinical studies reveal that adjuvant GH treatment has a possible role in vitro fertilization …

[HTML][HTML] Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteria

L Hu, Z Bu, Y Guo, Y Su, J Zhai… - International journal of …, 2014 - ncbi.nlm.nih.gov
Many protocols have been proposed to improve IVF outcomes for poor ovarian responders.
The aim of this study was to explore the relationship between age, ovarian hyperstimulation …

The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials

P Yang, R Wu, H Zhang - Reproductive Biology and Endocrinology, 2020 - Springer
Purpose The aim of this meta-analysis was to evaluate the effect of growth hormone (GH)
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …

Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the …

F Li, T Ye, H Kong, J Li, L Hu, HX Jin… - Frontiers in …, 2021 - frontiersin.org
The mechanisms underlying poor ovarian response (POR) in assisted reproductive
technology remain unclear, there is no consensus on the management of poor responders …

The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic …

XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - journals.lww.com
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria—the why

SC Esteves, M Roque, GM Bedoschi… - Frontiers in …, 2018 - frontiersin.org
Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous
gonadotropin stimulation present a challenge for reproductive specialists. The primary …